Priceline Group Inc. (PCLN) Financials Nov 14, 2014, 7:57
Priceline Group Inc. (PCLN) Financials Nov 14, 2014, 7:57 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Priceline Group Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 2.34B 3.08B 4.36B 5.26B 6.79B
Cost of Goods Sold (COGS) incl. D&A 1.3B 1.49B 1.68B 1.69B 1.87B
COGS excluding D&A 1.26B 1.44B 1.63B 1.62B 1.76B
Depreciation & Amortization Expense 39.19M 50.46M 53.82M 65.14M 117.98M
Depreciation 14.49M 16.21M 20.65M 32.82M 48.37M
Amortization of Intangibles 24.7M 34.26M 33.18M 32.32M 69.61M
Gross Income 1.04B 1.59B 2.67B 3.57B 4.92B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 567.88M 804.64M 1.27B 1.72B 2.48B
Research & Development 0 0 0 0 0
Other SG&A 567.88M 804.64M 1.27B 1.72B 2.48B
Other Operating Expense 0 0 0 0 0
Unusual Expense 4.9M 14.4M 0 27M 55.7M
EBIT after Unusual Expense (4.9M) (14.4M) 0 (27M) (55.7M)
Non Operating Income/Expense (5.67M) (3.13M) (7.53M) (9.72M) (10.06M)
Non-Operating Interest Income 2.22M 3.86M 8.12M 3.86M 4.17M
Equity in Affiliates (Pretax) - - - - -
Interest Expense 22.88M 28.54M 31.72M 62.06M 83.29M
Gross Interest Expense 22.88M 28.54M 31.72M 62.06M 83.29M
Interest Capitalized 0 0 0 0 0
Pretax Income 442.3M 746.28M 1.37B 1.76B 2.3B
Income Tax (47.17M) 218.14M 308.66M 337.83M 403.74M
Income Tax - Current Domestic 3.91M 5.62M 12.37M 15.88M 18.68M
Income Tax - Current Foreign 101.21M 174.98M 251.54M 302.35M 396.16M
Income Tax - Deferred Domestic (144.13M) 46.85M 52.16M 33.39M 5.21M
Income Tax - Deferred Foreign (8.15M) (9.31M) (7.41M) (13.79M) (16.31M)
Income Tax Credits - - - - -
Equity in Affiliates 2,000 0 0 - -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 489.47M 528.14M 1.06B 1.42B 1.89B
Minority Interest Expense 0 601,000 2.76M 4.47M 135,000
Net Income 489.47M 527.54M 1.06B 1.42B 1.89B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 489.47M 527.54M 1.06B 1.42B 1.89B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 489.47M 527.54M 1.06B 1.42B 1.89B
EPS (Basic) 11.54 11.00 21.27 28.48 37.17
Basic Shares Outstanding 42.41M 47.96M 49.65M 49.84M 50.92M
EPS (Diluted) 9.88 10.35 20.63 27.66 36.11
Diluted Shares Outstanding 49.52M 50.99M 51.21M 51.33M 52.41M
EBITDA 512.73M 838.96M 1.45B 1.92B 2.56B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...
Continue Reading
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...
Continue Reading
AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...
Continue Reading
Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...
Continue Reading
Top 5 Most Recently Viewed Articles
Replay Sports Cards Capitalizes on Trading Card Opportunities Trading cards are undergoing a radical transformation; what was once seen as a childhood pastime is now a robust business venture. The trading card market is expected to expand exponentially, with estimated sales skyrocketing from $14.9 billion in 2023 to an incredible $52.1 billion by 2034. This surge speaks...
Continue Reading
Moca Network's AIR Shop Revolutionizes Event Ticketing Experience Fans can now enjoy exciting new opportunities as Moca Network introduces AIR Shop Tickets, a remarkable platform that offers over 40 million tickets for concerts, sports, theater performances, and various live events. With this innovation, fans have a unique chance to earn up to 10% back on ticket purchases...
Continue Reading
Big Changes for Pediatric Heart Care in the PNW Ever find yourself stuck between a rock and a hard place when it comes to healthcare options for your kids? I swear, like clockwork, every time I think about the state of pediatric care, it sends me down memory lane—could be the dot-com bust vibes, you know? Anyway, Cincinnati Children's Hospital is teaming up with...
Continue Reading
Immuneering Corporation's Orphan Drug Designation Immuneering Corporation (NASDAQ:IMRX), a pioneering biotechnology firm in the oncology space, is making headlines with the recent designation of its drug candidate, IMM-1-104, as an orphan drug by the U.S. Food and Drug Administration (FDA). This recognition is a crucial step in the development of treatments aimed at rare...
Continue Reading
Applied Optoelectronics Introduces New Equity Grants for Employees In an exciting development, Applied Optoelectronics, Inc. (NASDAQ: AAOI) has announced that its board's Compensation Committee has awarded equity grants to new employees under their inducement plan. This initiative involves granting 11,860 shares of common stock to five new team members, with a specific...
Continue Reading